The 2014 Ebola outbreak shows that low trust in government can have disastrous consequences during health crises like the current COVID-19 pandemic.

"Before we encourage widespread use of a drug, we need better evidence that it's worth it," says ethicist Alex John London of hydroxychloroquine for COVID-19.

Creating a mutation in a key protein could stop the Ebola virus from evading immune defenses and making its hosts sick, researchers say.

A new treatment for Ebola shows huge promise for cutting the mortality rate, but researchers caution that we haven't cured the disease yet.

Last week, the World Health Organization declared the year-long Ebola outbreak in Congo a global health emergency. Did they wait too long?

A delay of just one week can drastically reduce the efficacy of Ebola vaccines in highly populated areas, research in the Democratic Republic of Congo finds.

During 2014's Ebola outbreak, there were no treatments on hand to fight the virus. Now, researchers have found a human protein that could change that.

When there's risk of a viral outbreak, fast diagnosis and treatment are key. A new test could change the time it takes to spot Ebola from days to minutes.

Based on observations from the 2014-2016 Ebola outbreak in West Africa, new research finds that a modified malaria drug can also combat the Ebola virus.